Skip to main content

The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion

Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.